Published in Women's Health Law Weekly, May 14th, 2006
The final data set was presented by Lilo Mettler, the study's principal investigator, at the 19th Annual European Congress of Obstetrics and Gynecology in Torino, Italy.
This randomized, controlled, single-blind, clinical study was designed to evaluate the safety and efficacy of Adhibit in reducing the incidence and severity of post-operative adhesions when applied immediately after the removal of uterine fibroids (myomectomy surgery). The study was conducted at six investigational sites in Europe, Canada, and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly